is now

Please update your bookmarks and favorites.
You will be taken to the new site in a few seconds.

Expert Consulting Services

Helping You Navigate the Changing Healthcare Landscape with Confidence

How do you plan to navigate the new CMS programs?

If you’re unsure about the changing regulatory requirements, new payment models and the complexities of the various government programs, you are not alone.

Inform Diagnostics team of certified health IT advisors are here to help you navigate the changing healthcare landscape with confidence. When you choose Inform Diagnostics, you work directly with one of our knowledgeable consultants who help guide your office every step of the way.

  • Understand CMS reporting rules
  • Get help with choosing which measures to report on
  • Learn the steps you can take now to succeed with Medicare quality reporting
Road Image

What is MACRA and how does it affect providers?

MACRA is the Medicare Access and CHIP Reauthorization Act. MACRA replaces the current Medicare reimbursement schedule with a new pay-for-performance program that’s focused on quality, value, and accountability. This new system, called the Quality Payment Program (QPP), repeals the Sustainable Growth Rate Formula and is made up of two participation tracks for payment—

  • Merit-Based Incentive Payment System (MIPS)
  • Advanced Alternative Payment Models (APMs)

If you are a clinician that bills services under the Medicare Physician Fee Schedule, understanding the requirements and payment changes under MACRA is crucial. The steps you take today will hit your practice’s bottom line tomorrow.

The first measurement period for the Quality Payment Program began January 1, 2017.

Helping Practices Avoid Penalties & Capture Incentives

Inform Diagnostics own health IT consultants have helped thousands of eligible clinicians and centers. Our certified advisors have provided comprehensive support for more than five years.

MIPS — Are you ready for the newest requirements?

If you’ve attested for CMS Quality Programs, are you ready for an audit—or trying to move forward after one?

Let Inform Diagnostics health IT consultants help your practice with:

  • Registration
  • Workflow training on each measure
  • Ongoing report review for each EC (eligible clinician)
  • Attestation and audit support for each EC
  • HIPAA compliance
  • Security assessments

Quality — Understand which measures to report, options for reporting, and how to seamlessly embed quality data reporting into your practice.

Cost — Get help with avoiding penalties and analyzing your new QRUR report as the industry goes to a pay-for-performance model.

Clinical Practice Improvement Activities (CPIA) — Let Inform Diagnostics help your practice select activities that easily align with new requirements and the workflow of your practice and the patients you serve.

Physician Compare Optimization — Ensure that your physicians are top-rated in your community. The new CMS Physician Compare website provides information for consumers. The site encourages consumers to make informed healthcare decisions. Through this, the site also creates explicit incentives for physicians to maximize their performance.

Both Physician Compare and MACRA scores will be published annually.

ASC Reporting — ASCs need to be ready to report the annual required data for ASC-6, 7, 8, 9 and 10, as well as complete a security risk assessment.

Experience Matters!

Our expert technical consultants have a wealth of experience:

  • Assisted more than 600 practices
  • 100% success in 2015 & 2016 with clients who have been audited by CMS!
  • More than 800 security risk analyses performed
  • Authors, trainers, coaches and certified HIT specialists
  • Meet author Joy Rios, one of our distinguished consultants
  • See what our clients say!

Contact Inform Diagnostics to learn how we can assist your practice.
Call 1.866.588.3280 or visit our Contact Page

If I have any questions, the Miraca dermatopathologists are easily accessible via a quick email or phone call.
— Josephine Chu McAllister, MD,
Dermatologist/Founder, Dermatology Associates of Ithaca, Ithaca, N.Y.

Learn about Miraca's unmatched quality. We provide our clients with access to the highest quality AP services.

Recent News

January 8, 2018

Miraca Life Sciences Announces Company Name Change to Inform Diagnostics

IRVING, Texas, January 8, 2018 — Miraca Life Sciences announced today that it has changed its name to Inform Diagnostics effective immediately. The company was acquired in November by Avista Capital Partners from previous owner Miraca Holdings. The name Inform Diagnostics and new logo were chosen to highlight the company’s focus on providing pathology and diagnostic capabilities that together help […]

Continue reading

November 20, 2017

Avista Capital Partners Completes Acquisition of Miraca Life Sciences

IRVING, Texas and NEW YORK, Nov. 20, 2017 — Avista Capital Partners (“Avista”), a leading private equity firm, today announced the completion of its acquisition of Miraca Life Sciences (“MLS” or the “Company”) from Miraca Holdings Inc.

Continue reading the press release at the Avista website.

Continue reading

October 16, 2017

Renflexis™ is Latest Addition to Therapeutic Drug Monitoring by Miraca Life Sciences

IRVING, Texas, October 16, 2017 — Miraca Life Sciences, the largest U.S. independent anatomic pathology laboratory, continues to expand in clinical pathology: its InformTx™ therapeutic drug monitoring (TDM) has begun the validation process for Renflexis™ (infliximab-abda), a biosimilar of Remicade® (infliximab). Testing will be commercially available in early November. Since launching the InformTx service in June 2016, Miraca Life Sciences […]

Continue reading

October 3, 2017

Biocept and Miraca Life Sciences Enter Into Marketing Agreement to Expand Target Selector Testing in the United States

MLS to market Biocept’s proprietary liquid biopsy testing platform in key sales territories, with potential to expand the agreement in the future

SAN DIEGO (October 3, 2017) – Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that it has entered […]

Continue reading

September 22, 2017

Avista Capital Partners to Acquire Miraca Life Sciences

IRVING, TX, NEW YORK, NY, and TOKYO, September 22, 2017 – Avista Capital Partners (“Avista”), a leading private equity firm, and Miraca Holdings Inc. (“MHD”) announced today that Avista has signed a definitive agreement to acquire Miraca Life Sciences (“MLS” or “the Company”), a wholly-owned subsidiary of Miraca Holdings Inc. Continue reading press release

Continue reading